February 28, 2022
HTL announces that Montagu, a leading private equity firm, has acquired a majority stake of HTL previously held by Bridgepoint. The other minority shareholders, Naxicap and Téthys Invest, will keep their shares in the company.
The arrival of this new shareholder symbolizes the international success of a company that has become the world leader in the development and production of pharmaceutical grade biopolymers.
news from us
Articles February 10, 2024
Happy Lunar New Year 2024 !
As we step into the Year of the Dragon, we extend our warmest wishes to all our colleagues, clients, partners, and friends celebrating this joyous occasion.
Articles February 3, 2024
HTL Biotechnology at IMCAS world congress 2024
IMCAS, the world’s leading congress dedicated to dermatology, plastic surgery and aesthetics.
Articles January 17, 2024
HTL Biotechnology will be at IMCAS 2024 !
We are excited to announce that we will be participating in the IMCAS 2024 Congress !
Join us for an immersive scientific program with innovation at its core, and network with the world’s leading figures and experts in dermatology and aesthetics.
We can’t wait to see you there !